Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials

Fig. 1

Change from baseline in systolic blood pressure (SBP). Change from baseline in SBP at Week 26 (a) and proportion of patients with SBP < 130 mmHg and < 140 mmHg at Week 26 (b). CI confidence interval; LS least squares. *Placebo-adjusted difference in LS mean (95% CI). Of patients with baseline SBP of ≥ 130 mmHg. Of patients with baseline SBP of ≥ 140 mmHg. §Difference in response rate (95% CI)

Back to article page